Quince Therapeutics, Inc. (QNCX)
1.07
+0.08
(+7.56%)
USD |
NASDAQ |
May 19, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics EPS Diluted (TTM) : -9.102 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -1.202 |
| BioXcel Therapeutics, Inc. | -6.190 |
| Gossamer Bio, Inc. | -0.7877 |
| Ernexa Therapeutics, Inc. | -30.72 |
| Acurx Pharmaceuticals, Inc. | -4.404 |